{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:57:51Z","timestamp":1782997071373,"version":"3.54.5"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","award":["11220080100106 (CF)"],"award-info":[{"award-number":["11220080100106 (CF)"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Baron Foundation","award":["2012-0656 (FONCyT)"],"award-info":[{"award-number":["2012-0656 (FONCyT)"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jneuroim.2014.11.023","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T20:24:21Z","timestamp":1417292661000},"page":"30-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Chronic systemic IL-1\u03b2 exacerbates central neuroinflammation independently of the blood\u2013brain barrier integrity"],"prefix":"10.1016","volume":"278","author":[{"given":"Ver\u00f3nica","family":"Murta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Far\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Juan","family":"Pitossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina Cintia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.11.023_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10072-009-0155-2","article-title":"Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS","volume":"31","author":"Aggelakis","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbi.2011.10.011","article-title":"The systemic response to brain injury and disease","volume":"26","author":"Anthony","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0015","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood\u2013brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood\u2013brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-5728(95)00113-5","article-title":"Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1 beta, interferon-gamma and TNF-alpha on cultured cells","volume":"62","author":"Bebo","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0030","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.0801485","article-title":"Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis","volume":"182","author":"Bennett","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0035","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1097\/00001756-199611040-00083","article-title":"Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes","volume":"7","author":"Bluthe","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00281-009-0182-3","article-title":"Progressive multiple sclerosis","volume":"31","author":"Bradl","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0050","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.91.24.11393","article-title":"Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration","volume":"91","author":"Breder","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0055","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/365642a0","article-title":"Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen","volume":"365","author":"Brocke","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0060","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.45.6_Suppl_6.S16","article-title":"Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species","volume":"45","author":"Brosnan","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0065","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/brain\/awf098","article-title":"Prospective study on the relationship between infections and multiple sclerosis exacerbations","volume":"125","author":"Buljevac","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/NEN.0b013e3181654957","article-title":"Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain","volume":"67","author":"Campbell","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0075","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.neuropharm.2008.06.074","article-title":"Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord","volume":"55","author":"Campbell","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.20072404","article-title":"The Th17\u2013ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease","volume":"205","author":"Carlson","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.0b013e3181ce5db0","article-title":"Younger children with MS have a distinct CSF inflammatory profile at disease onset","volume":"74","author":"Chabas","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","article-title":"Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system","volume":"22","author":"Chen","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuroscience.2005.08.087","article-title":"Peripheral injection of lipopolysaccharide prevents brain recruitment of leukocytes induced by central injection of interleukin-1","volume":"137","author":"Ching","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0140","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1523\/JNEUROSCI.3357-07.2007","article-title":"Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration","volume":"27","author":"Ching","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(02)00030-1","article-title":"Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease","volume":"112","author":"Combrinck","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.wco.0000169740.91416.a2","article-title":"Clinical trials in multiple sclerosis: methodological issues","volume":"18","author":"Comi","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0095","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/1352458511418027","article-title":"The impact of environmental infections (parasites) on MS activity","volume":"17","author":"Correale","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2011.01.002","article-title":"The impact of parasite infections on the course of multiple sclerosis","volume":"233","author":"Correale","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1530-0277.1992.tb00707.x","article-title":"Ambient temperature effects on taste aversion conditioned by ethanol: contribution of ethanol-induced hypothermia","volume":"16","author":"Cunningham","year":"1992","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0110","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1128\/JVI.79.8.5174-5184.2005","article-title":"Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease","volume":"79","author":"Cunningham","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0115","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"Cunningham","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopsych.2008.07.024","article-title":"Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease","volume":"65","author":"Cunningham","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0150","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1749-6632.1998.tb09597.x","article-title":"Cytokines and sickness behavior","volume":"840","author":"Dantzer","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.11.004","article-title":"The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy","volume":"207","author":"Dujmovic","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0170","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1523\/JNEUROSCI.18-22-09471.1998","article-title":"Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins","volume":"18","author":"Ek","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0175","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cne.903610410","article-title":"Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation","volume":"361","author":"Ericsson","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0185","first-page":"436813","article-title":"Parkinson's disease and systemic inflammation","volume":"2011","author":"Ferrari","year":"2011","journal-title":"Park. Dis."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0180","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63438-4","article-title":"Reversible demyelination, blood\u2013brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain","volume":"165","author":"Ferrari","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-7-76","article-title":"IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients","volume":"7","author":"Fiala","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2012.01.061","article-title":"Central nervous system inflammation in disease related conditions: mechanistic prospects","volume":"1446","author":"Fung","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.gt.3302805","article-title":"HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35\u201355)-induced experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"14","author":"Furlan","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0205","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease","volume":"131","author":"Godoy","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0210","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1523\/JNEUROSCI.19-07-02799.1999","article-title":"Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?","volume":"19","author":"Goehler","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0215","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S1462399411001918","article-title":"Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases","volume":"13","author":"Grammas","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.jneuroim.2014.11.023_bb0220","doi-asserted-by":"crossref","first-page":"v30","DOI":"10.1007\/s00415-005-5006-3","article-title":"Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis","volume":"252","author":"Hartung","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0225","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.40.11.1735","article-title":"Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6","volume":"40","author":"Hauser","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-5-15","article-title":"Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia","volume":"5","author":"Henry","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbi.2008.09.002","article-title":"Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines","volume":"23","author":"Henry","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0240","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1352458512440060","article-title":"Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein","volume":"18","author":"Herges","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2008.06.034","article-title":"MHC class II exacerbates demyelination in vivo independently of T cells","volume":"203","author":"Hiremath","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0250","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0255","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.nbd.2006.06.012","article-title":"Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1beta","volume":"23","author":"Howe","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/156720210790820226","article-title":"Interleukin-1beta plays a role in the activation of peripheral leukocytes after blood\u2013brain barrier rupture in the course of subarachnoid hemorrhage","volume":"7","author":"Jedrzejowska-Szypulka","year":"2010","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0265","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/092986705774462833","article-title":"Anti-inflammatory immunotherapy for multiple sclerosis\/experimental autoimmune encephalomyelitis (EAE) disease","volume":"12","author":"Kanwar","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0270","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1172\/JCI13362","article-title":"TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models","volume":"107","author":"Kassiotis","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.wco.0000169735.60922.fb","article-title":"Multiple sclerosis\u2014novel insights and new therapeutic strategies","volume":"18","author":"Kieseier","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0280","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-4522(98)00368-6","article-title":"Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain","volume":"89","author":"Konsman","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0285","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cne.20052","article-title":"Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli","volume":"472","author":"Konsman","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0300","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1990.tb00927.x","article-title":"Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures","volume":"81","author":"Kruger","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0305","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","article-title":"How do immune cells overcome the blood\u2013brain barrier in multiple sclerosis?","volume":"585","author":"Larochelle","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0310","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cne.903060310","article-title":"Efferent projections from the periventricular and medial parvicellular subnuclei of the hypothalamic paraventricular nucleus to circumventricular organs of the rat: a Phaseolus vulgaris-leucoagglutinin (PHA-L) tracing study","volume":"306","author":"Larsen","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0315","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbi.2010.09.009","article-title":"Endothelial IL-1R1 is a critical mediator of EAE pathogenesis","volume":"25","author":"Li","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0320","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1352458511399797","article-title":"The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment","volume":"17","author":"Lindquist","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0330","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nn.2491","article-title":"CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis","volume":"13","author":"Liu","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0325","first-page":"60","article-title":"Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1","volume":"1","author":"Liu","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0335","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/dvg.22401","article-title":"Functional defect of peripheral neutrophils in mice with induced deletion of CXCR2","volume":"51","author":"Liu","year":"2013","journal-title":"Genesis"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0340","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0345","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00018-012-0989-2","article-title":"Type I IFN-mediated regulation of IL-1 production in inflammatory disorders","volume":"69","author":"Ludigs","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-5728(91)90073-G","article-title":"Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis","volume":"32","author":"Maimone","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0355","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0360","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/intimm\/dxh379","article-title":"Abnormal T cell activation caused by the imbalance of the IL-1\/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis","volume":"18","author":"Matsuki","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0365","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/BST0370329","article-title":"The effects of blood\u2013brain barrier disruption on glial cell function in multiple sclerosis","volume":"37","author":"McQuaid","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0370","first-page":"305","article-title":"Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling","volume":"1","author":"Mizwicki","year":"2012","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0375","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ana.22550","article-title":"Systemic inflammation induces axon injury during brain inflammation","volume":"70","author":"Moreno","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mcn.2012.06.004","article-title":"Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models","volume":"53","author":"Murta","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0385","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bbi.2012.07.007","article-title":"CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved","volume":"26","author":"Murta","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005072-199901000-00008","article-title":"Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge","volume":"58","author":"Nadeau","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0395","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2011.11.009","article-title":"Neutrophils in multiple sclerosis are characterized by a primed phenotype","volume":"242","author":"Naegele","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/glia.20246","article-title":"Role for CXCR2 and CXCL1 on glia in multiple sclerosis","volume":"53","author":"Omari","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0405","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/(SICI)1097-4547(19960915)45:6<776::AID-JNR14>3.0.CO;2-U","article-title":"Treatment with lipopolysaccharide enhances the pathogenicity of a low-pathogenic variant of Theiler's murine encephalomyelitis virus","volume":"45","author":"Palma","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0410","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neuroscience.2006.04.007","article-title":"Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats","volume":"141","author":"Pang","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0415","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ana.410360709","article-title":"Influence of infection on exacerbations of multiple sclerosis","volume":"36","author":"Panitch","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0420","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0425","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0430","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1046\/j.1460-9568.2003.02969.x","article-title":"Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS","volume":"18","author":"Penderis","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0440","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbi.2004.01.004","article-title":"The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease","volume":"18","author":"Perry","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0450","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/297683a0","article-title":"Evidence for dendritic competition in the developing retina","volume":"297","author":"Perry","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0435","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00019052-200206000-00020","article-title":"Atypical inflammation in the central nervous system in prion disease","volume":"15","author":"Perry","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0455","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrn1032","article-title":"The impact of systemic infection on the progression of neurodegenerative disease","volume":"4","author":"Perry","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0445","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0465","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2010.02.018","article-title":"Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression","volume":"222","author":"Pott Godoy","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0470","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1073\/pnas.92.24.11294","article-title":"Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha","volume":"92","author":"Probert","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0475","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12035-008-8026-z","article-title":"Immune-to-brain signaling: how important are the blood\u2013brain barrier-independent pathways?","volume":"37","author":"Quan","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0480","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0306-4522(97)00350-3","article-title":"Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide","volume":"83","author":"Quan","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0485","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0490","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/156652412799218895","article-title":"Involvement of IL-1R\/TLR signalling in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"12","author":"Ruggiero","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0495","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4049\/jimmunol.1000126","article-title":"Meningeal mast cells affect early T cell central nervous system infiltration and blood\u2013brain barrier integrity through TNF: a role for neutrophil recruitment?","volume":"184","author":"Sayed","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0500","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/2529511","article-title":"The analysis of ranked data derived from completely randomized factorial designs","volume":"32","author":"Scheirer","year":"1976","journal-title":"Biometrics"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0505","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1073\/pnas.90.18.8543","article-title":"Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis","volume":"90","author":"Schiffenbauer","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0510","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/clim.2000.4851","article-title":"The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor","volume":"95","author":"Schiffenbauer","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0515","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0520","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410230405","article-title":"Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro","volume":"23","author":"Selmaj","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0525","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1523\/JNEUROSCI.0406-09.2009","article-title":"Systemic inflammatory response reactivates immune-mediated lesions in rat brain","volume":"29","author":"Serres","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0530","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1042\/BST0351122","article-title":"Interleukin-1 and inflammatory neurodegeneration","volume":"35","author":"Simi","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0535","doi-asserted-by":"crossref","first-page":"e69123","DOI":"10.1371\/journal.pone.0069123","article-title":"A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1beta, TNF-alpha and IL-6 challenges in C57BL\/6 mice","volume":"8","author":"Skelly","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0540","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0361-9230(01)00730-4","article-title":"Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"56","author":"Sly","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0545","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0555","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neuroscience.2008.07.031","article-title":"Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms","volume":"158","author":"Teeling","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0550","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbi.2009.11.006","article-title":"The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1","volume":"24","author":"Teeling","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0560","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0022-510X(91)90315-X","article-title":"Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis","volume":"104","author":"Tsukada","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0565","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1046\/j.1471-4159.1997.69041668.x","article-title":"Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta","volume":"69","author":"Vallieres","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0570","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/endo.140.9.6983","article-title":"Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia","volume":"140","author":"Vallieres","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0575","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/glia.20266","article-title":"Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord","volume":"53","author":"Vallieres","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1096\/fasebj.10.2.8641570","article-title":"Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction?","volume":"10","author":"Van Dam","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.02.016","article-title":"Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?","volume":"246","author":"Veenstra","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0590","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","article-title":"Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination","volume":"252","author":"Warabi","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0595","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/ern.10.13","article-title":"Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination","volume":"10","author":"Watzlawik","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0600","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21640","article-title":"The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?","volume":"65","author":"Weiner","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0610","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/glia.20546","article-title":"Astrocytes\u2014friends or foes in multiple sclerosis?","volume":"55","author":"Williams","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0605","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0615","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00418-009-0673-2","article-title":"Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"133","author":"Wu","year":"2010","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0620","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/01.wnl.0000336918.32695.6b","article-title":"Impaired hypothalamic\u2013pituitary\u2013adrenal axis activity in patients with multiple sclerosis","volume":"71","author":"Ysrraelit","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.11.023_bb0625","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awm291","article-title":"Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection","volume":"131","author":"Zeis","year":"2008","journal-title":"Brain"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814009849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814009849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:23:42Z","timestamp":1759047822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572814009849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":125,"alternative-id":["S0165572814009849"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.11.023","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic systemic IL-1\u03b2 exacerbates central neuroinflammation independently of the blood\u2013brain barrier integrity","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}